Title: Immunostimulatory siRNA Molecules and Uses Thereof
Filed: June 30, 2005
Lead Inventor: Ian MacLachlan, Protiva Biotherapeutics
The invention "provides siRNA molecules and methods of using such siRNA molecules to modulate an immune response and to silence expression of a target gene," the patent application's abstract states.
Title: RNA Interference-Mediated Inhibition of Protein Tyrosine Phosphate-1B Gene Expression Using Short Interfering Nucleic Acid